Literature DB >> 18239458

Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer's disease brain.

Bilal Malik1, Antonio Currais, Ana Andres, Christopher Towlson, Didier Pitsi, Ana Nunes, Michael Niblock, Jonathan Cooper, Tibor Hortobágyi, Salvador Soriano.   

Abstract

Presenilin-1 (PS1) is a component of the beta-catenin degradation machinery, and PS1 mutations linked to familial Alzheimer's disease (FAD) represent a loss of this function, leading, in non-neuronal cells, to accumulation of cyclin D1, aberrant cell cycle activation and hyperproliferation. In post-mitotic neurons, cell cycle activation is thought to be abortive and initiate apoptosis, thus contributing to AD pathogenesis. Consequently, we tested here the hypothesis that, in the PS1 FAD brain, cyclin D1 accumulation may occur and lead to neuronal apoptosis secondary to an abortive entry into the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18239458     DOI: 10.4161/cc.7.5.5427

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  29 in total

1.  Absence of disturbed axonal transport in spinal and bulbar muscular atrophy.

Authors:  Bilal Malik; Niranjanan Nirmalananthan; Lynsey G Bilsland; Albert R La Spada; Michael G Hanna; Giampietro Schiavo; Jean-Marc Gallo; Linda Greensmith
Journal:  Hum Mol Genet       Date:  2011-02-11       Impact factor: 6.150

2.  SILAC-based proteomic analysis to investigate the impact of amyloid precursor protein expression in neuronal-like B103 cells.

Authors:  Dale Chaput; Lisa Hornbeck Kirouac; Harris Bell-Temin; Stanley M Stevens; Jaya Padmanabhan
Journal:  Electrophoresis       Date:  2012-12       Impact factor: 3.535

3.  Up-Regulation of PKM2 Relates to Retinal Ganglion Cell Apoptosis After Light-Induced Retinal Damage in Adult Rats.

Authors:  Xiaowei Yang; Hui Chen; Manhui Zhu; Rongrong Zhu; Bai Qin; Hongda Fang; Ming Dai; Aimin Sang; Xiaojuan Liu
Journal:  Cell Mol Neurobiol       Date:  2015-05-20       Impact factor: 5.046

4.  Caffeine modulates tau phosphorylation and affects Akt signaling in postmitotic neurons.

Authors:  Antonio Currais; Kiyoko Kato; Leonides Canuet; Ryouhei Ishii; Toshihisa Tanaka; Masatoshi Takeda; Salvador Soriano
Journal:  J Mol Neurosci       Date:  2010-09-14       Impact factor: 3.444

Review 5.  The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease.

Authors:  Craig S Atwood; Richard L Bowen
Journal:  Horm Behav       Date:  2015-07-16       Impact factor: 3.587

Review 6.  The neuronal cell cycle as a mechanism of pathogenesis in Alzheimer's disease.

Authors:  Antonio Currais; Tibor Hortobágyi; Salvador Soriano
Journal:  Aging (Albany NY)       Date:  2009-04-28       Impact factor: 5.682

Review 7.  A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis.

Authors:  Craig S Atwood; Richard L Bowen
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  Genetic dissection of gamma-secretase-dependent and -independent functions of presenilin in regulating neuronal cell cycle and cell death.

Authors:  Verena Kallhoff-Munoz; Lingyun Hu; Xiaoli Chen; Robia G Pautler; Hui Zheng
Journal:  J Neurosci       Date:  2008-10-29       Impact factor: 6.167

Review 9.  Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease.

Authors:  Hyoung-Gon Lee; Gemma Casadesus; Xiongwei Zhu; Rudy J Castellani; Andrew McShea; George Perry; Robert B Petersen; Vladan Bajic; Mark A Smith
Journal:  Neurochem Int       Date:  2008-12-09       Impact factor: 3.921

10.  Molecular profiling reveals diversity of stress signal transduction cascades in highly penetrant Alzheimer's disease human skin fibroblasts.

Authors:  Graziella Mendonsa; Justyna Dobrowolska; Angela Lin; Pooja Vijairania; Y-J I Jong; Nancy L Baenziger
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.